Love is in the air—and so are big savings! 💖 Get 50% off on All Access with the code ILOVERESEARCH before this offer breaks up! Save 50%

Exploration of Targeted Anti-tumor Therapy : Impact Factor & More

eISSN: 2692-3114
JournalOpen Access

Check your submission readiness

Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.

Topics Covered on Exploration of Targeted Anti-tumor Therapy

Pioneer factor
Breast cancer
Immune checkpoint inhibitors
Liquid biopsy
Tamoxifen
Ovarian cancer
Adjuvant therapy
Immunotherapy

Exploration of Targeted Anti-tumor Therapy Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Open Exploration Publishing Inc.
Language English
Publication Time13
Editorial Review ProcessBlind peer review
See specification for 4 more categories

Recently Published Papers in Exploration of Targeted Anti-tumor Therapy

Exploration of Targeted Anti-tumor Therapy Year-wise Publication

FAQs on Exploration of Targeted Anti-tumor Therapy

How many articles did Exploration of Targeted Anti-tumor Therapy publish last year? expand

In 2024, Exploration of Targeted Anti-tumor Therapy publsihed 83 articles.

Who is the publisher of Exploration of Targeted Anti-tumor Therapy? expand

Open Exploration Publishing Inc. is the publisher of Exploration of Targeted Anti-tumor Therapy.